Application of metabolomics to preeclampsia diagnosis

References

• Altun ZS, Uysal S, Guner G, Yilmaz O, Posaci C. 2008. Effects of oral L‐arginine supplementation on blood pressure and asymmetric dimethylarginine in stress‐induced preeclamptic rats. Cell Biochem Funct. 26(5):648–653.
   PubMed Web of Science ®Google Scholar
• Austdal M, Skråstad RB, Gundersen AS, Austgulen R, Iversen A-C, Bathen TF. 2014. Metabolomic biomarkers in serum and urine in women with preeclampsia. PLoS One. 9(3):e91923.
   PubMed Web of Science ®Google Scholar
• Austdal M, Tangerås LH, Skråstad RB, Salvesen K, Austgulen R, Iversen A-C, Bathen TF. 2015a. First trimester urine and serum metabolomics for prediction of preeclampsia and gestational hypertension: a prospective screening study. Int J Mol Sci. 16(9):21520–21538.
   PubMed Web of Science ®Google Scholar
• Austdal M, Thomsen LCV, Tangerås LH, Skei B, Mathew S, Bjørge L, Austgulen R, Bathen TF, Iversen A-C. 2015b. Metabolic profiles of placenta in preeclampsia using HR-MAS MRS metabolomics. Placenta. 36(12):1455–1462.
   PubMed Web of Science ®Google Scholar
• Bahado-Singh R, Poon LC, Yilmaz A, Syngelaki A, Turkoglu O, Kumar P, Kirma J, Allos M, Accurti V, Li J, et al. 2017a. Integrated proteomic and metabolomic prediction of term preeclampsia. Sci Rep. 7(1):16189.
   Google Scholar
• Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K. 2012. Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 25(10):1840–1847. eng.
   PubMed Web of Science ®Google Scholar
• Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K. 2013. First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 208(1):58.e1–7.
   PubMed Web of Science ®Google Scholar
• Bahado-Singh RO, Syngelaki A, Akolekar R, Mandal R, Bjondahl TC, Han B, Dong E, Bauer S, Alpay-Savasan Z, Graham S. 2015. Validation of metabolomic models for prediction of early-onset preeclampsia. Am J Obstet Gynecol. 213(4):530.e531–530. e510.
   PubMed Web of Science ®Google Scholar
• Bahado-Singh RO, Syngelaki A, Mandal R, Graham SF, Akolekar R, Han B, Bjondahl TC, Dong E, Bauer S, Alpay-Savasan Z, et al. 2017b. Metabolomic determination of pathogenesis of late-onset preeclampsia. J Matern Fetal Neonatal Med. 30(6):658–664. eng.
   PubMed Web of Science ®Google Scholar
• Berks D, Hoedjes M, Raat H, Duvekot J, Steegers E, Habbema J. 2013. Risk of cardiovascular disease after pre‐eclampsia and the effect of lifestyle interventions: a literature‐based study. BJOG: Int J Obstetrics Gynaecol. 120(8):924–931.
   PubMed Web of Science ®Google Scholar
• Bolin M, Åkerud P, Hansson A, Åkerud H. 2011. Histidine-rich glycoprotein as an early biomarker of preeclampsia. Am J Hypertens. 24(4):496–501.
   PubMed Web of Science ®Google Scholar
• Borzychowski AM, Sargent IL, Redman CWG. 2006. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med. 11(5):309–316.
   Google Scholar
• Braghiroli A, Sacco C, Erbetta M, Ruga V, Donner CF. 1993. Overnight urinary uric acid: creatinine ratio for detection of sleep hypoxemia. Am Rev Respir Dis. 148(1):173–178.
   PubMed Web of Science ®Google Scholar
• Cetin I, Marconi AM, Bozzetti P, Sereni LP, Corbetta C, Pardi G, Battaglia FC. 1988. Imbilical amino acid concentrations in appropriate and small for gestational age infants: a biochemical difference present in utero. Am J Obstetrics Gynecol. 158(1):120–126.
   PubMed Web of Science ®Google Scholar
• Chao C-Y, Lii C-K, Ye S-Y, Li -C-C, Lu C-Y, Lin A-H, Liu K-L, Chen H-W. 2014. Docosahexaenoic acid inhibits vascular endothelial growth factor (VEGF)-induced cell migration via the GPR120/PP2A/ERK1/2/eNOS signaling pathway in human umbilical vein endothelial cells. J Agric Food Chem. 62(18):4152–4158.
   PubMed Web of Science ®Google Scholar
• Chen T, He P, Tan Y, Xu D. 2017. Biomarker identification and pathway analysis of preeclampsia based on serum metabolomics. Biochem Biophys Res Commun. 485(1):119–125. eng.
   PubMed Web of Science ®Google Scholar
• Chen X-C, Pan Z-L, Liu D-S, Han X. 1998. Effect of taurine on human fetal neuron cells: proliferation and differentiation. Taurine. 3:397–403.
   Google Scholar
• Cnossen JS, Riet GT, Mol BW, Van Der Post JA, Leeflang MM, Meads CA, Hyde C, Khan KS. 2009. Are tests for predicting pre‐eclampsia good enough to make screening viable? A review of reviews and critical appraisal. Acta Obstet Gynecol Scand. 88(7):758–765.
   PubMed Web of Science ®Google Scholar
• Desforges M, Ditchfield A, Hirst CR, Pegorie C, Martyn-Smith K, Sibley CP, Greenwood SL. 2013a. Reduced placental taurine transporter (TauT) activity in pregnancies complicated by pre-eclampsia and maternal obesity. Taurine. 8:81–91.
   Google Scholar
• Desforges M, Parsons L, Westwood M, Sibley C, Greenwood S. 2013b. Taurine transport in human placental trophoblast is important for regulation of cell differentiation and survival. Cell Death Dis. 4(3):e559.
   PubMedGoogle Scholar
• Diareme M, Karkalousos P, Theodoropoulos G, Strouzas S, Lazanas N. 2009. Lipid profile of healthy women during normal pregnancy. J Med Biochem. 28(3):152–160.
   Web of Science ®Google Scholar
• Diaz SO, Barros AS, Goodfellow BJ, Duarte IF, Galhano E, Pita C, Almeida Mdo C, Carreira IM, Gil AM. 2013. Second trimester maternal urine for the diagnosis of trisomy 21 and prediction of poor pregnancy outcomes. J Proteome Res. 12(6):2946–2957. eng.
   PubMed Web of Science ®Google Scholar
• Drake SK, Bowen RA, Remaley AT, Hortin GL. 2004. Potential interferences from blood collection tubes in mass spectrometric analyses of serum polypeptides. Clinic Chem. 50(12):2398–2401.
   PubMed Web of Science ®Google Scholar
• Dunn WB, Brown M, Worton SA, Davies K, Jones RL, Kell DB, Heazell AEP. 2012. The metabolome of human placental tissue: investigation of first trimester tissue and changes related to preeclampsia in late pregnancy. Metabolomics. 8(4):579–597.
   Web of Science ®Google Scholar
• Dunn WB, Ellis DI. 2005. Metabolomics: current analytical platforms and methodologies. TrAC Trends Anal Chem. 24(4):285–294.
   Web of Science ®Google Scholar
• Emwas A-H, Luchinat C, Turano P, Tenori L, Roy R, Salek RM, Ryan D, Merzaban JS, Kaddurah-Daouk R, Zeri AC. 2015. Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review. Metabolomics. 11(4):872–894.
   PubMed Web of Science ®Google Scholar
• Emwas A-HM, Salek RM, Griffin JL, Merzaban J. 2013. NMR-based metabolomics in human disease diagnosis: applications, limitations, and recommendations. Metabolomics. 9(5):1048–1072.
   Web of Science ®Google Scholar
• Enaruna NO, Idemudia JO, Aikoriogie PI. 2014. Serum lipid profile and uric acid levels in preeclampsia in University of Benin Teaching Hospital. Niger Med J. 55(5):423.
   PubMedGoogle Scholar
• Famularo G, Simone C, Trinchieri V, Mosca L. 2004. Carnitines and its congeners: a metabolic pathway to the regulation of immune response and inflammation. Ann N Y Acad Sci. 1033(1):132–138.
   PubMedGoogle Scholar
• Ghezzi P, Dinarello CA, Bianchi M, Rosandich ME, Repine JE, White CW. 1991. Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. Cytokine. 3(3):189–194.
   PubMed Web of Science ®Google Scholar
• Ghoochani BFNM, Aliannejad R, Oskouie AA, Rezaei-Tavirani M, Kalantari S, Naseri MT, Baghban AA, Parastar H, Aliakbarzadeh G. 2018. Metabolomics diagnostic approach to mustard airway diseases: a preliminary study. Iran J Basic Med Sci. 21(1):59.
   PubMed Web of Science ®Google Scholar
• Gofman JW, Delalla O, Glazier F, Freeman NK, Lindgren FT, Nichols AV, Strisower B, Tamplin AR. 2007. The serum lipoprotein transport system in health, metabolic disorders, atherosclerosis and coronary heart disease. J Clin Lipidol. 1(2):104–141.
   PubMed Web of Science ®Google Scholar
• He L, Wang Z, Sun Y. 2004. Reduced amount of cytochrome c oxidase subunit I messenger RNA in placentas from pregnancies complicated by preeclampsia. Acta Obstet Gynecol Scand. 83(2):144–148.
   PubMed Web of Science ®Google Scholar
• Hishikawa K, Nakaki T, Suzuki H, Kato R, Saruta T. 1993. Role of L-arginine-nitric oxide pathway in hypertension. J Hypertens. 11(6):639–645.
   PubMed Web of Science ®Google Scholar
• Hubel CA. 1999. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med. 222(3):222–235.
   PubMed Web of Science ®Google Scholar
• Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR. 2011. 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension. 57(1):63–69.
   PubMed Web of Science ®Google Scholar
• Jain S, Jayasimhulu K, Clark JF. 2004. Metabolomic analysis of molecular species of phospholipids from normotensive and preeclamptic human placenta electrospray ionization mass spectrometry. Front Biosci: J Virtual Library. 9:3167–3175. eng.
   PubMedGoogle Scholar
• Jones DR, Schmidt RJ, Pickard RT, Foxworthy PS, Eacho PI. 2002. Estrogen receptor-mediated repression of human hepatic lipase gene transcription. J Lipid Res. 43(3):383–391.
   PubMed Web of Science ®Google Scholar
• Kalantari S, Nafar M, Samavat S, Parvin M, Gh NM, Fatemeh B, Barzi F. 2016. 1H NMR‐based metabolomics exploring urinary biomarkers correlated with proteinuria in focal segmental glomerulosclerosis: a pilot study. Magn Reson Chem. 54(10):821–826.
   Web of Science ®Google Scholar
• Kårehed K, Wikström AK, Olsson AK, Larsson A, Olovsson M, Åkerud H. 2010. Fibrinogen and histidine‐rich glycoprotein in early‐onset preeclampsia. Acta Obstet Gynecol Scand. 89(1):131–139.
   PubMed Web of Science ®Google Scholar
• Kenny LC, Broadhurst D, Brown M, Dunn WB, Redman CW, Kell DB, Baker PN. 2008. Detection and identification of novel metabolomic biomarkers in preeclampsia. Reprod Sci. 15(6):591–597.
   PubMed Web of Science ®Google Scholar
• Kenny LC, Broadhurst DI, Dunn W, Brown M, North RA, McCowan L, Roberts C, Cooper GJ, Kell DB, Baker PN. 2010. Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers. Hypertension. 56(4):741–749.
   PubMed Web of Science ®Google Scholar
• Kenny LC, Dunn WB, Ellis DI, Myers J, Baker PN, Kell DB, Consortium G. 2005. Novel biomarkers for pre-eclampsia detected using metabolomics and machine learning. Metabolomics. 1(3):227–234.
   Web of Science ®Google Scholar
• Keshavarz P, Gh BFNM, Mirhafez SR, Nematy M, Azimi-Nezhad M, Afin SA, Esmaily H, Pourali L, Hakak AM, Soukhtanloo M. 2017. Alterations in lipid profile, zinc and copper levels and superoxide dismutase activities in normal pregnancy and preeclampsia. Am J Med Sci. 353(6):552–558.
   PubMed Web of Science ®Google Scholar
• Klausen T, Olsen NV, Poulsen TD, Richalet J-P, Pedersen BK. 1997. Hypoxemia increases serum interleukin-6 in humans. Eur J Appl Physiol. 76(5):480–482.
   Web of Science ®Google Scholar
• Koster MP, Vreeken RJ, Harms AC, Dane AD, Kuc S, Schielen PC, Hankemeier T, Berger R, Visser GH, Pennings JL. 2015. First-trimester serum acylcarnitine levels to predict preeclampsia: a metabolomics approach. Dis Mark. 2015:857108. eng.
   Google Scholar
• Kuc S, Koster MP, Pennings JL, Hankemeier T, Berger R, Harms AC, Dane AD, Schielen PC, Visser GH, Vreeken RJ. 2014. Metabolomics profiling for identification of novel potential markers in early prediction of preeclampsia. PLoS One. 9(5):e98540. eng.
   PubMed Web of Science ®Google Scholar
• Laffel L. 1999. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev. 15(6):412–426.
   PubMed Web of Science ®Google Scholar
• Lauridsen M, Hansen SH, Jaroszewski JW, Cornett C. 2007. Human urine as test material in 1H NMR-based metabonomics: recommendations for sample preparation and storage. Anal Chem. 79(3):1181–1186.
   PubMed Web of Science ®Google Scholar
• Lima V, Andrade C, Ruschi GE, Sass N. 2011. Serum lipid levels in pregnancies complicated by preeclampsia. Sao Paulo Med J. 129(2):73–76.
   PubMed Web of Science ®Google Scholar
• Manten G, Sikkema J, Franx A, Hameeteman T, Visser G, De Groot P, Voorbij H. 2003. Increased high molecular weight fibrinogen in pre-eclampsia. Thromb Res. 111(3):143–147.
   PubMed Web of Science ®Google Scholar
• Monteiro M, Carvalho M, Bastos M, Guedes de Pinho P. 2013. Metabolomics analysis for biomarker discovery: advances and challenges. Curr Med Chem. 20(2):257–271.
   PubMed Web of Science ®Google Scholar
• Mukherjee R, Ray CD, Ray S, Dasgupta S, Chaudhury K. 2014. Altered metabolic profile in early and late onset preeclampsia: an FTIR spectroscopic study. Pregnancy Hypertens. 4(1):70–80. eng.
   PubMed Web of Science ®Google Scholar
• Nelson RH. 2013. Hyperlipidemia as a risk factor for cardiovascular disease. Primary Care. 40(1):195.
   PubMed Web of Science ®Google Scholar
• Nicholson JK, Lindon JC. 2008. Systems biology: metabonomics. Nature. 455(7216):1054.
   PubMed Web of Science ®Google Scholar
• Niewczas MA, Sirich TL, Mathew AV, Skupien J, Mohney RP, Warram JH, Smiles A, Huang X, Walker W, Byun J. 2014. Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study. Kidney Int. 85(5):1214–1224.
   PubMed Web of Science ®Google Scholar
• Nobakht BF, Aliannejad R, Rezaei-Tavirani M, Arefi Oskouie A, Naseri MT, Parastar H, Aliakbarzadeh G, Fathi F, Taheri S. 2016a. NMR-and GC/MS-based metabolomics of sulfur mustard exposed individuals: a pilot study. Biomarkers. 21(6):479–489.
   PubMed Web of Science ®Google Scholar
• Nobakht BF, Arefi Oskouie A, Rezaei-Tavirani M, Aliannejad R, Taheri S, Fathi F, Taghi Naseri M. 2017. NMR spectroscopy-based metabolomic study of serum in sulfur mustard exposed patients with lung disease. Biomarkers. 22(5):413–419.
   PubMed Web of Science ®Google Scholar
• Nobakht M, Aliannejad R, Oskouie A, Fathi F, Safakhah H, Rezaei-Tavirani M. 2016b. Nuclear magnetic resonance-based metabolomics analysis of patients exposed to sulfur mustard in different stages using random forest method. Koomesh. 17:3.
   Google Scholar
• Nobakht MGBF, Aliannejad R, Rezaei-Tavirani M, Taheri S, Oskouie AA. 2015. The metabolomics of airway diseases, including COPD, asthma and cystic fibrosis. Biomarkers. 20(1):5–16.
   PubMed Web of Science ®Google Scholar
• Odibo AO, Goetzinger KR, Odibo L, Cahill AG, Macones GA, Nelson DM, Dietzen DJ. 2011. First‐trimester prediction of preeclampsia using metabolomic biomarkers: a discovery phase study. Prenat Diagn. 31(10):990–994.
   PubMed Web of Science ®Google Scholar
• Polsani S, Phipps E, Jim B. 2013. Emerging new biomarkers of preeclampsia. Adv Chronic Kidney Dis. 20(3):271–279.
   PubMed Web of Science ®Google Scholar
• Poon L, Kametas N, Chelemen T, Leal A, Nicolaides K. 2010. Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. J Hum Hypertens. 24(2):104.
   PubMed Web of Science ®Google Scholar
• Reuvekamp A, Velsing‐Aarts FV, Poulina IE, Capello JJ, Duits AJ. 1999. Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre‐eclampsia. BJOG: Int J Obstetrics Gynaecol. 106(10):1019–1022.
   Google Scholar
• Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. 1989. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 161(5):1200–1204.
   PubMed Web of Science ®Google Scholar
• Ruiz-Núñez B, Dijck-Brouwer DJ, Muskiet FA. 2016. The relation of saturated fatty acids with low-grade inflammation and cardiovascular disease. J Nutr Biochem. 36:1–20.
   PubMed Web of Science ®Google Scholar
• Rytting E, Audus KL. 2007. Effects of low oxygen levels on the expression and function of transporter OCTN2 in BeWo cells. J Pharm Pharmacol. 59(8):1095–1102.
   PubMed Web of Science ®Google Scholar
• Sánchez-Aranguren LC, Prada CE, Riaño-Medina CE, Lopez M. 2014. Endothelial dysfunction and preeclampsia: role of oxidative stress. Front Physiol. 5:1–11.
   Web of Science ®Google Scholar
• Scalbert A, Brennan L, Fiehn O, Hankemeier T, Kristal BS, van Ommen B, Pujos-Guillot E, Verheij E, Wishart D, Wopereis S. 2009. Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research. Metabolomics. 5(4):435.
   PubMed Web of Science ®Google Scholar
• Scheepers LE, Boonen A, Pijnenburg W, Bierau J, Staessen JA, Stehouwer CD, Thijs C, Arts IC. 2017. Associations of plasma uric acid and purine metabolites with blood pressure in children: the KOALA Birth Cohort Study. J Hypertens. 35(5):982–993.
   PubMed Web of Science ®Google Scholar
• Senyavina NV, Khaustova SA, Grebennik TK, Pavlovich SV. 2013. Analysis of purine metabolites maternal serum for evaluating the risk of gestosis. Bull Exp Biol Med. 155(5):682–684.
   PubMed Web of Science ®Google Scholar
• Sibai B, Dekker G, Kupferminc M. 2005. Pre-eclampsia. Lancet. 365(9461):785–799.
   PubMed Web of Science ®Google Scholar
• Sibai BM. 1992. Hypertension in pregnancy. Obstet Gynecol Clin North Am. 19(4):615–632.
   PubMed Web of Science ®Google Scholar
• Sibai BM, Gordon T, Thom E, Caritis SN, Klebanoff M, McNellis D, Paul RH. 1995. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. Am J Obstet Gynecol. 172(2):642–648.
   PubMed Web of Science ®Google Scholar
• Simantov R, Febbraio M, Crombie R, Asch AS, Nachman RL, Silverstein RL. 2001. Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1. J Clin Invest. 107(1):45.
   PubMed Web of Science ®Google Scholar
• Slupsky CM, Rankin KN, Wagner J, Fu H, Chang D, Weljie AM, Saude EJ, Lix B, Adamko DJ, Shah S. 2007. Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Anal Chem. 79(18):6995–7004.
   PubMed Web of Science ®Google Scholar
• Staff AC. 2011. Circulating predictive biomarkers in preeclampsia. Pregnancy Hypertens. 1(1):28–42.
   PubMed Web of Science ®Google Scholar
• Tarcin O, Yavuz DG, Ozben B, Telli A, Ogunc AV, Yuksel M, Toprak A, Yazici D, Sancak S, Deyneli O. 2009. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metabol. 94(10):4023–4030.
   PubMed Web of Science ®Google Scholar
• Thiele IG, Niezen-Koning KE, van Gennip AH, Aarnoudse JG. 2004. Increased plasma carnitine concentrations in preeclampsia. Obstet Gynecol. 103(5, Part 1):876–880.
   PubMed Web of Science ®Google Scholar
• Tsuji M, Murota S-I, Morita I. 2003. Docosapentaenoic acid (22: 5, n-3) suppressed tube-forming activity in endothelial cells induced by vascular endothelial growth factor. Prostaglandins Leukot Essent Fatty Acids. 68(5):337–342.
   PubMed Web of Science ®Google Scholar
• Vadillo-Ortega F, Perichart-Perera O, Espino S, Avila-Vergara MA, Ibarra I, Ahued R, Godines M, Parry S, Macones G, Strauss JF. 2011. Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial. BMJ. 342:d2901.
   PubMed Web of Science ®Google Scholar
• Vikse BE, Irgens LM, Leivestad T, Skjærven R, Iversen BM. 2008. Preeclampsia and the risk of end-stage renal disease. New England J Med. 359(8):800–809.
   PubMed Web of Science ®Google Scholar
• Walsh SW. 2007. Obesity: a risk factor for preeclampsia. Trends Endocrinol Metabol. 18(10):365–370.
   PubMed Web of Science ®Google Scholar
• Wang JH, Byun J, Pennathur S. 2010. Analytical approaches to metabolomics and applications to systems biology. Semin Nephrol. 30(5):500–511.
   Google Scholar
• Wei S-Q, Qi H-P, Luo Z-C, Fraser WD. 2013. Maternal vitamin D status and adverse pregnancy outcomes: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 26(9):889–899.
   PubMed Web of Science ®Google Scholar
• Wikström A-K, Larsson A, Eriksson UJ, Nash P, Nordén-Lindeberg S, Olovsson M. 2007. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia. Obstet Gynecol. 109(6):1368–1374.
   PubMed Web of Science ®Google Scholar
• Williams VK, Griffiths AB, Carbone S, Hague WM. 2007. Fibrinogen concentration and factor VIII activity in women with preeclampsia. Hypertens Pregnan. 26(4):415–421.
   PubMed Web of Science ®Google Scholar
• Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, Hau DD, Psychogios N, Dong E, Bouatra S. 2008. HMDB: a knowledgebase for the human metabolome. Nucl Acids Res. 37(suppl_1):D603–D610.
   PubMedGoogle Scholar
• Wójcik OP, Koenig KL, Zeleniuch-Jacquotte A, Costa M, Chen Y. 2010. The potential protective effects of taurine on coronary heart disease. Atherosclerosis. 208(1):19–25.
   PubMed Web of Science ®Google Scholar
• Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. 2000. Decreased bioavailability of vitamin D in obesity–. Am J Clin Nutr. 72(3):690–693.
   PubMed Web of Science ®Google Scholar
• Yanes O, Tautenhahn R, Patti GJ, Siuzdak G. 2011. Expanding coverage of the metabolome for global metabolite profiling. Anal Chem. 83(6):2152–2161.
   PubMed Web of Science ®Google Scholar
• Zehua W, Guanglan Z, Meihua L. 1999. Mitochondrial tRNA leu (UUR) gene mutation and the decreased activity of cytochrome c oxidase in preeclampsia. J Huazhong Univ Sci Technol Med Sci. 19(3):209–211.
   Google Scholar
• Zhou X, Han TL, Chen H, Baker PN, Qi H, Zhang H. 2017. Impaired mitochondrial fusion, autophagy, biogenesis and dysregulated lipid metabolism is associated with preeclampsia. Exp Cell Res. 359(1):195–204. eng.
   PubMed Web of Science ®Google Scholar